European Case Law Identifier: | ECLI:EP:BA:2002:T065399.20020918 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 18 September 2002 | ||||||||
Case number: | T 0653/99 | ||||||||
Application number: | 90915320.7 | ||||||||
IPC class: | C12N 5/10 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Modified Biological Material | ||||||||
Applicant name: | IMUTRAN LIMITED | ||||||||
Opponent name: | Nextran, Inc. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Partial admissibility of an opposition - no Remittal to the first instance for complete re-examination - yes Substantial procedural violation - yes |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t990653eu1.html
Date retrieved: 17 May 2021